Xu Q - Search Results

1

Iguratimod suppresses plasma cell differentiation and ameliorates experimental Sjögren's syndrome in mice by promoting TEC kinase degradation.

Yang YQ, Liu YJ, Qiao WX, Jin W, Zhu SW, Yan YX, Luo Q, Xu Q. Yang YQ, et al. Among authors: xu q. Acta Pharmacol Sin. 2024 Sep;45(9):1926-1936. doi: 10.1038/s41401-024-01288-7. Epub 2024 May 14. Acta Pharmacol Sin. 2024. PMID: 38744938

2

An autonomous activation of interleukin-17 receptor signaling sustains inflammation and promotes disease progression.

Luo Q, Liu Y, Shi K, Shen X, Yang Y, Liang X, Lu L, Qiao W, Chen A, Hong D, Sun Y, Xu Q. Luo Q, et al. Among authors: xu q. Immunity. 2023 Sep 12;56(9):2006-2020.e6. doi: 10.1016/j.immuni.2023.06.012. Epub 2023 Jul 19. Immunity. 2023. PMID: 37473759 Free article.

3

Natural compound fraxinellone ameliorates intestinal fibrosis in mice via direct intervention of HSP47-collagen interaction in the epithelium.

Wang J, Bai M, Zhang C, An N, Wan L, Wang XN, Du RH, Shen Y, Yuan ZY, Wu XD, Wu XF, Xu Q. Wang J, et al. Among authors: xu q. Acta Pharmacol Sin. 2023 Dec;44(12):2469-2478. doi: 10.1038/s41401-023-01143-1. Epub 2023 Aug 14. Acta Pharmacol Sin. 2023. PMID: 37580493 Free PMC article.

4

Citrate-Based Polyester Elastomer with Artificially Regulatable Degradation Rate on Demand.

Wan L, Lu L, Liang X, Liu Z, Huang X, Du R, Luo Q, Xu Q, Zhang Q, Jia X. Wan L, et al. Among authors: xu q. Biomacromolecules. 2023 Sep 11;24(9):4123-4137. doi: 10.1021/acs.biomac.3c00479. Epub 2023 Aug 16. Biomacromolecules. 2023. PMID: 37584644

5

TP53INP2 modulates the malignant progression of colorectal cancer by reducing the inactive form of β-catenin.

Shi K, Shan Y, Sun X, Chen K, Luo Q, Xu Q. Shi K, et al. Among authors: xu q. Biochem Biophys Res Commun. 2024 Jan 1;690:149275. doi: 10.1016/j.bbrc.2023.149275. Epub 2023 Nov 19. Biochem Biophys Res Commun. 2024. PMID: 37995453

6

G-quadruplex structures in FGFR3 promoter negatively regulate its gene expression and DNA replication.

Shi K, Chen K, Lu S, Luo Q, Xu Q. Shi K, et al. Among authors: xu q. Biochem Biophys Res Commun. 2024 Oct 20;730:150384. doi: 10.1016/j.bbrc.2024.150384. Epub 2024 Jul 10. Biochem Biophys Res Commun. 2024. PMID: 39003866

7

New opportunities and challenges of natural products research: When target identification meets single-cell multiomics.

Zhu Y, Ouyang Z, Du H, Wang M, Wang J, Sun H, Kong L, Xu Q, Ma H, Sun Y. Zhu Y, et al. Among authors: xu q. Acta Pharm Sin B. 2022 Nov;12(11):4011-4039. doi: 10.1016/j.apsb.2022.08.022. Epub 2022 Aug 27. Acta Pharm Sin B. 2022. PMID: 36386472 Free PMC article. Review.

8

Allosterically activating SHP2 by oleanolic acid inhibits STAT3-Th17 axis for ameliorating colitis.

Hu J, Liu W, Zou Y, Jiao C, Zhu J, Xu Q, Zou J, Sun Y, Guo W. Hu J, et al. Among authors: xu q. Acta Pharm Sin B. 2024 Jun;14(6):2598-2612. doi: 10.1016/j.apsb.2024.03.017. Epub 2024 Mar 18. Acta Pharm Sin B. 2024. PMID: 38828149 Free PMC article.

9

Indolocarbazole alkaloid Loonamycin A inhibits triple-negative breast cancer cell stemness and Notch signalling.

Xue W, Li W, Yu Y, Zhang B, Wang Y, Zhou L, Chen Z, Wang L, Ge H, Xu Q, Shen Y. Xue W, et al. Among authors: xu q. J Pharm Pharmacol. 2023 Apr 7;75(4):523-532. doi: 10.1093/jpp/rgad007. J Pharm Pharmacol. 2023. PMID: 36861187

10

Polydatin-Mediated Inhibition of HSP90α Disrupts NLRP3 Complexes and Alleviates Acute Pancreatitis.

Yang J, Jiao C, Liu N, Liu W, Wang Y, Pan Y, Kong L, Guo W, Xu Q. Yang J, et al. Among authors: xu q. Research (Wash D C). 2024 Dec 17;7:0551. doi: 10.34133/research.0551. eCollection 2024. Research (Wash D C). 2024. PMID: 39691768 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20,329 results

Search Page

Filters